Clinical Trial

Drug-drug Interaction Study Between UIC202304, and UIC202305

Name: Drug-drug Interaction Study Between UIC202304, and UIC202305 — clinical trial record (NCT07735052)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

A randomized, open-label, two-sequence, two-period, multiple-dose, study to evaluate pharmacokinetic drug-drug interaction, safety and tolerability of UIC202304 and UIC202305 in healthy volunteers.

Trial Details

NCT Number	NCT07735052
Lead Sponsor	Korea United Pharm. Inc.
Conditions	Healhty
Enrollment	40 participants
Start Date	2023-09-25
Primary Completion	2023-11-24 (estimated)
Study Completion	2024-09-09 (estimated)
Updated on ClinicalTrials.gov	2026-07-29